Location History:
- Charenton le Pont, FR (2020)
- Nogent sur Marne, FR (2021)
Company Filing History:
Years Active: 2020-2021
Title: Stéphane Melik Parsadaniantz: Innovator in Ocular Treatments
Introduction
Stéphane Melik Parsadaniantz is a notable inventor based in Nogent-Sur-Marne, France. He has made significant contributions to the field of ocular treatments, holding 2 patents that focus on innovative methods for preventing and treating eye inflammation.
Latest Patents
His latest patents include "Aminophosphinic derivatives for preventing and treating eye inflammation." This patent discloses compounds designed to treat various ocular conditions, including keratitis, scleritis, and glaucoma. The compounds aim to improve ocular healing and prevent neovascularization. Another significant patent is "Methods of treating eye pain with aminophosphinic derivatives." This patent outlines a method for alleviating eye pain through the administration of specific compounds.
Career Highlights
Throughout his career, Stéphane has worked with prominent companies such as Pharmaleads and Iacta Pharmaceuticals, Inc. His work has focused on developing innovative solutions for eye-related ailments, showcasing his dedication to improving patient care.
Collaborations
Stéphane has collaborated with notable professionals in his field, including Hervé Poras and Michel Wurm. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Stéphane Melik Parsadaniantz is a distinguished inventor whose work in ocular treatments has the potential to significantly impact the field of ophthalmology. His innovative patents reflect his commitment to enhancing the quality of life for individuals suffering from eye conditions.